Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2008
11/12/2008EP1989209A2 Organic compounds
11/12/2008EP1989204A1 Pyrazoloquinolones are potent parp inhibitors
11/12/2008EP1751138B9 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2008CN101305010A Raf inhibitor compounds and methods of use thereof
11/12/2008CN101304975A P2X7 receptor antagonists and uses thereof
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/11/2008US7449588 by treatment with basic compounds consisting of calcium oxide, magnesium oxide, barium oxide, aluminium oxide, oxide hydroxides thereof and mixtures; to avoid the changes in color or formation of secondary components
11/11/2008US7449580 Ticlopidine and clopidogrel simply prepared by reacting a substituted thiophene derivative with a 2-chlorobenzylamine derivative
11/11/2008US7449490 Pharmaceutically active compounds and methods of use
11/11/2008US7449480 Small molecule inhibitors of HER2 expression
11/11/2008US7449472 Methods of inhibiting p38 with substituted bicyclic pyrimidines
11/11/2008US7449464 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
11/06/2008WO2008134480A1 Non-basic melanin concentrating hormone receptor-1 antagonists
11/06/2008WO2008133288A1 Tricyclic aryl compounds
11/06/2008WO2008133274A1 Aminodihydrothiazine derivatives substituted with cyclic groups
11/06/2008WO2008133128A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133127A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008131835A1 Organic semiconductors
11/06/2008WO2008075155A3 Carbonic anhydrase inhibitors derivatives
11/06/2008WO2008027949A3 Thieno pyrimidine compounds
11/06/2008US20080275066 3-Methanesulfonyl-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrobenzo[c]thiophene-1-carboxylic acid 2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl ester; for treatment of metabolic disorders such as IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity
11/06/2008US20080275026 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
11/06/2008CA2683887A1 Aminodihydrothiazine derivatives substituted with a cyclic group
11/06/2008CA2682519A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008CA2682400A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/05/2008EP1988092A1 A process for the preparation of olanzapine
11/05/2008EP1988088A1 Thiolactones
11/05/2008EP1987020A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1986646A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
11/05/2008EP1986645A1 Glucokinase activators
11/05/2008EP1638980B1 Process for preparing 3-aminothienopyridone derivatives
11/05/2008CN100430403C 3-aryl-5,6-substituted thienopyrimidine-4-carbonyl-2-mercaptoacetonitrile, and its synthesizing method and use
11/05/2008CN100430401C 4-phenyl substd. tetrahydroisoquinolines and therapeutic use thereof
11/04/2008US7446200 Condensing 4,5,6,7-Tetrahydrothieno [3,2-c] pyridine hydrochloride with alpha -bromo-2-chloroquine acetic acid methyl ester in an organic solvent in presence of an inorganic base to obtain racemic Clopidogrel base; resolving using levo rotatory camphor-10- sulphonic acid, purification
10/2008
10/30/2008WO2008131119A2 Composition and method for cancer treatment and prevention
10/30/2008WO2008130951A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
10/30/2008WO2008128982A1 Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008059368A3 Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
10/30/2008WO2007147104A3 Novel compounds
10/30/2008US20080269228 Hydrazide-containing hepatitis c serine protease inhibitors
10/30/2008US20080269210 Using 1-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno(3,2-d)pyrimifin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfony)ethanone; lipid kinase inhibitor; anticancer agents
10/30/2008US20080269110 Non-basic melanin concentrating hormone receptor-1 antagonists
10/30/2008US20080267911 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/29/2008EP1984377A2 Inhibitors of tnf alpha , pde4 and b-raf, compositions thereof and methods of use therewith
10/29/2008EP1660504B1 Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents
10/29/2008EP1164121B1 Novel carboxylic acid derivatives and process for producing the same
10/29/2008CN101296929A Tricyclic compounds useful as oxytocin receptor agonists
10/29/2008CN101293890A Novel synthesizing method for dorzolamide HCL midbody
10/28/2008US7442812 Substituted benzopyrans as selective estrogen receptor-beta agonists
10/28/2008US7442808 e.g. 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline; with other active ingredients; agonists of G-protein coupled receptor 40 (GPR40); antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity, hyperlipemia
10/28/2008CA2448735C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
10/23/2008WO2008128072A2 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
10/23/2008WO2008127029A1 Dioxypyrrolo-heteroaromatic compounds and organic electronic devices using the same
10/23/2008WO2008064829A3 Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof
10/23/2008US20080262076 Novel Tetracyclic Tetrahydrofuran Derivatives Containing Cyclic Amine Side Chain
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080262015 therapeutically active 2,4,5-trisubstituted imidazole compounds; alone or in combination; high antineoplastic activity, low systemic toxicity and low mutagenicity on normal cells; inhibitors of p38 MAP kinase; modulators of multi-drug resistance in cancer cells
10/23/2008US20080261971 Novel Heterocyclic Nf-Kb Inhibitors
10/23/2008US20080261968 Heterobicyclic metalloprotease inhibitors
10/23/2008US20080261951 Condensed azepines as vasopressin agonists
10/23/2008US20080260749 Novel Tetrahydropyridothiophenes
10/23/2008CA2682733A1 Axl kinase inhibitors
10/22/2008EP1981892A1 Thieno-pyridine derivatives as mek inhibitors
10/22/2008EP1814886B1 A process for the preparation of n-demethylolanzapine
10/22/2008EP1594879B1 Process and intermediates for the preparation of olanzapine
10/22/2008EP1554284B1 Method for manufacturing crystalline form i of clopidogrel hydrogen sulphate
10/22/2008CN101291938A Compounds and compositions as protein kinase inhibitors
10/22/2008CN101291937A Fused tricyclic mgiur1 antagonists as therapeutic agents
10/22/2008CN101291936A Fused tricyclic mglur1 antagonists as therapeutic agents
10/22/2008CN101289454A Method for preparing 2-oxygen-2,4,5,6,7,7alpha-hexahydro thieno [3,2-c]pyridine
10/22/2008CN101289451A Pentacyclic fused heterocycle compounds with chinoline backbone and method for preparing same
10/21/2008US7439264 Therapeutic compounds
10/21/2008US7439253 for example: the triethylammonium salt of 5,6-dihydro-6-oxo-N2-phenyl-5(sulfoxy)-4H-4,7-methanopyrazolo[3,4-e][1,3]diazepine-2,8(8H)-dicarboxamide
10/21/2008US7439247 Bicyclic pyridine and pyrimidine P38 kinase inhibitors
10/21/2008CA2210913C Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
10/16/2008WO2008124610A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008WO2008124083A2 Aurora kinase modulators and method of use
10/16/2008WO2008124000A2 Thiazole derivatives as androgen receptor modulator compounds
10/16/2008WO2008122513A1 Heterocycles as orexin antagonists
10/16/2008US20080255184 N-[3-(4-amino-7-pyridin-3-ylthieno[3,2-c]pyridin-3-yl)phenyl]-N'-[2-fluoro-5-(trifluoromethyl)phenyl]urea; lymphoma, melanoma, small cell lung , non-small cell lung, breast, colon and pancreatic cancer
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255120 Substituted 2,5-heterocyclic derivatives
10/16/2008CA2683431A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008CA2681163A1 Heterocycles as orexin antagonists
10/15/2008EP1980563A1 Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
10/15/2008EP1980560A2 C-glycoside derivatives for the treatment of diabetes
10/15/2008EP1693374B1 Microcrystal and medicinal preparation containing the same
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008CN101284838A Ethylene imine derivates with thienopyridine, preparation method and applications thereof
10/15/2008CN101284837A Stereoselective total synthesis method of (+)-biotin
10/14/2008US7435834 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008121877A2 Cftr inhibitor compounds and uses thereof
10/09/2008WO2008120761A1 Heteroaryl derivative
10/09/2008WO2008119657A1 Imidazolidinone derivatives
10/09/2008WO2008057873A3 Inhibitors of hepatitis c virus
10/09/2008WO2008057871A3 Inhibitors of hepatitis c virus
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 214